Markowski Mark C, Pirsl Filip, Keruly Jeanne C, Chander Geetanjali, Moore Richard D, Lau Bryan, Joshu Corinne E
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Prostate Cancer Prostatic Dis. 2024 Mar;27(1):144-146. doi: 10.1038/s41391-022-00586-7. Epub 2022 Sep 3.
10-year outcomes in patients living with HIV who are diagnosed with prostate cancer are unknown.
52 patients living with HIV were diagnosed with prostate cancer. Disease-free survival stratified by clinical, pathologic, and HIV characteristics were examined.
No difference in disease-free survival was observed based on prostate cancer treatment modality, CD4 count, or HIV viral load.
Prostate cancer outcomes in patients living with HIV are favorable irrespective of treatment modality.
感染艾滋病毒且被诊断患有前列腺癌的患者的10年预后情况尚不清楚。
52名感染艾滋病毒的患者被诊断患有前列腺癌。对按临床、病理和艾滋病毒特征分层的无病生存率进行了检查。
基于前列腺癌治疗方式、CD4细胞计数或艾滋病毒病毒载量,未观察到无病生存率存在差异。
无论治疗方式如何,感染艾滋病毒患者的前列腺癌预后良好。